title: T cell avidity and tumor immunity: problems and solutions.
abstract: A potent T cell response is an important component of durable anti-tumor immunity. The quality of the T cell response can, in-part, be measured by the avidity of the T cell for its tumor antigen-expressing target. While convention suggests that raising the avidity of the responding T cells may make for a more potent anti-tumor immune response, the threshold for effective tumor immunity remains unclear, as do some of the adverse effects of an inappropriately high avidity response. In this review, we discuss the relationship between T cell avidity and anti-tumor immunity, considering both experimental model systems as well as human clinical trials.
authors.affiliation: Tumor Immunity and Tolerance Section, Cancer and Inflammation Program, National Cancer Institute, 211 Building 567, NCI-Frederick, Frederick, MD, 21702, USA, hurwitza@mail.nih.gov.
authors.forename: Arthur A
authors.initials: AA
authors.lastname: Hurwitz
authors.forename: Steven M
authors.initials: SM
authors.lastname: Cuss
authors.forename: Katherine E
authors.initials: KE
authors.lastname: Stagliano
authors.forename: Ziqiang
authors.initials: Z
authors.lastname: Zhu